Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207752 · ClinicalTrials.gov registry record · NA
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
A NA study of Meibomian Gland Dysfunction, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT01207752 is a NA study of Meibomian Gland Dysfunction that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 69 participants, below the 94-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01207752, a NA study of Meibomian Gland Dysfunction, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study will be to determine the efficacy of this novel, lipid-containing artificial tear on the signs and symptoms of meibomian gland disease.
Conditions Studied
Interventions
- DRUG Systane Balance
- DRUG Optive Lubricant Eye Drops
Study Locations (1)
California
- Eye Care Center - Fullerton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207752
The ClinicalTrials.gov registry entry for NCT01207752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 94-participant average among 8 other Meibomian Gland Dysfunction trials with a reported enrollment target (27% lower). The listed sponsor is Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Meibomian Gland Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Systane Balance is the first listed.
NCT01207752 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01207752 about?
NCT01207752 is a clinical study titled "The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction". The aim of this study will be to determine the efficacy of this novel, lipid-containing artificial tear on the signs and symptoms of meibomian gland disease.
What is the current status of trial NCT01207752?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2010-09. Estimated completion is 2011-07.
What conditions does trial NCT01207752 study?
This clinical trial studies the following conditions: Meibomian Gland Dysfunction.
What interventions are being tested in trial NCT01207752?
The interventions under investigation include: Systane Balance (DRUG), Optive Lubricant Eye Drops (DRUG).
Who is sponsoring clinical trial NCT01207752?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01207752 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meibomian Gland Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Meibomian Gland Dysfunction Management
ACTIVE NOT RECRUITING · NA
-
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
ACTIVE NOT RECRUITING · NA
-
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
COMPLETED · NA
-
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
COMPLETED · NA
-
Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye Disease
COMPLETED · NA
-
Tear Film Innovations iLux Safety Study
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.